Genome Sequence of SG33 Strain and Recombination between Wild-Type and Vaccine Myxoma Viruses

Camus-Bouclainville, Christelle; Gretillat, Magalie; Py, Robert; Gelfi, Jacqueline; Guérin, Jean-Luc; Bertagnoli, Stéphane

doi:10.3201/eid1704.101146

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Genome Sequence of SG33 Strain and Recombination between Wild-Type and Vaccine Myxoma Viruses

Apr 2011
By Camus-Bouclainville, Christelle ; Gretillat, Magalie ; Py, Robert ; ...
http://dx.doi.org/10.3201/eid1704.101146
Source: Emerg Infect Dis. 17(4):633-638.

[PDF-363.74 KB]

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Camus-Bouclainville, Christelle ; Gretillat, Magalie ; Py, Robert ; Gelfi, Jacqueline ; Guérin, Jean-Luc ; ... More +

Camus-Bouclainville, Christelle ; Gretillat, Magalie ; Py, Robert ; Gelfi, Jacqueline ; Guérin, Jean-Luc ; Bertagnoli, Stéphane Less -
Description:

Myxomatosis in Europe is the result of the release of a South America strain of myxoma virus in 1952. Several attenuated strains with origins in South America or California have since been used as vaccines in the rabbit industry. We sequenced the genome of the SG33 myxoma virus vaccine strain and compared it with those of other myxoma virus strains. We show that SG33 genome carries a large deletion in its right end. Furthermore, our data strongly suggest that the virus isolate from which SG33 is derived results from an in vivo recombination between a wild-type South America (Lausanne) strain and a California MSD-derived strain. These findings raise questions about the use of insufficiently attenuated virus in vaccination.
Subjects:

[+]

Animals Genetic Recombination Genome, Viral Molecular Sequence Data Myxomatosis, Infectious Myxoma Virus Poxviridae Rabbits Recombination, Genetic Research Sequence Analysis, DNA Sequence Homology, Nucleic Acid Vaccines Viruses
Source:

Emerg Infect Dis. 17(4):633-638.
Document Type:

Journal Article
Volume:

17
Issue:

4
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:a4ed51cad4af4828c946909a21173f2f861267e5defc7e6df48d00b3f6498a35
Download URL:

https://stacks.cdc.gov/view/cdc/24311/cdc_24311_DS1.pdf
File Type:

	10-1146-F.gif	gif
	10-1146-F.jpg	jpeg
	10-1146_finalR.nxml	txt
	license.txt	txt

More +